| For: | Shi L, Zhou L, Han M, Zhang Y, Zhang Y, Yuan XX, Lu HP, Wang Y, Yang XL, Liu C, Wang J, Liang P, Liu SA, Liu XJ, Cheng J, Lin SM. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways. World J Gastroenterol 2023; 29(18): 2798-2817 [PMID: 37274069 DOI: 10.3748/wjg.v29.i18.2798] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i18/2798.htm |
| Number | Citing Articles |
| 1 |
Lixing Xu, Jie Yang, Xinyu Cao, Jiayi Chen, Zhikuan Liu, Liangliang Cai, Yanyan Yu, Haiqin Huang. Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery. International Journal of Pharmaceutics 2024; 664 doi: 10.1016/j.ijpharm.2024.124607
|
| 2 |
Sijoon Lee. Systemic histopathological responses to nanoplastic exposure: a review of cellular toxicity and organ-level pathology in mammalian systems. Toxicology Mechanisms and Methods 2026; doi: 10.1080/15376516.2026.2699441
|
| 3 |
Liu Shi, Gong Feng, Xueliang Yang, Yang Zhang, Yu Zhang, Jun Cheng, Shumei Lin. Potential of PAQosome as a therapeutic target for hepatic fibrosis. Journal of Gastroenterology and Hepatology 2024; 39(2) doi: 10.1111/jgh.16427
|
| 4 |
Linao Zhang, Yuanmei Bai, Shifang Luo, Feifan Liu, Lijie Zheng, Yan Wan, Xue Wu, Qinghua Chen, Yuhuan Xie, Peixin Guo, Palash Mandal. Experimental Study of YaJieShaBa Antialcoholic Hepatic Fibrosis Through TGF‐β1/Smad Signaling Pathway. Mediators of Inflammation 2026; 2026(1) doi: 10.1155/mi/2319470
|
| 5 |
Mengyao Zhu, Lu Ren, Wenlong Xiao, Longjian Wang, Zhiming Hu, Nani Wang. Senkyunolide I suppresses hepatic stellate cell activation and liver fibrosis by reprogramming VDR-dependent fatty acid metabolism. Chinese Medicine 2025; 20(1) doi: 10.1186/s13020-025-01133-x
|
| 6 |
Qingqing Zhang, Ziheng Zhang, Nannan Song, Chongzheng Pang, Fanglong Hu, Jianpeng Li, Can Liu, Aiya Zhao, Jinting Chen, Baohua Chen, Baoku Li, Shaoyong Zhuang, Chengyan Zhou. PB2 alleviates diabetic nephropathy: Intervene gut-flora-dependent metabolite TMAO promote DN-associated inflammatory responses through ferroptosis, ER stress–autophagy axis, and macrophage polarization. Journal of Pharmaceutical Analysis 2026; doi: 10.1016/j.jpha.2026.101705
|
| 7 |
Mehrasa Zakeri, Atefe Panahipoor Javaherdehi, Ahmad Torkashvand, Alireza Zafarani, Mohammad Hossein Razizadeh. The role of NF-κB signaling pathway in viral hepatitis and gastroenteritis: pathogenesis and therapeutic applications. Future Virology 2024; 19(10-11) doi: 10.1080/17460794.2024.2415216
|
| 8 |
Shiqi Chen, Zhu Wu, Jing Zhang, Yuxin Lin, Jiaqi Xie, Dehui Yin, Ye Zhu. Research and application of medicines for treating liver fibrosis: current status and prospects. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1582258
|
| 9 |
Yanting Hu, Zhongrui Zhang, Akida Adiham, Hong Li, Jian Gu, Puyang Gong. In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration. International Journal of Molecular Sciences 2025; 26(2) doi: 10.3390/ijms26020696
|